Skip to main content
OpenTrials

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

453 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Recruiting

A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

NCT06773195

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Massachusetts General Hospital (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Recruiting

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

NCT07020533

Conditions
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +38 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia

NCT07394153

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Hospital del Mar Barcelona Barcelona, Spain
  • Hospital Universitario Vall d´Hebron Barcelona, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • Hospital Universitario de Jerez Jerez de la Frontera, Cádiz, Spain
View all 13 locations
View Trial Details
Recruiting

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

NCT07623161

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +4 more
Locations
  • Los Angeles Cancer Network Glendale, California, United States
  • Cancer and Blood Specialty Clinic Whittier, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Advanced Research, LLC Coral Springs, Florida, United States
View all 207 locations
View Trial Details
Recruiting

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

NCT07441694

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • City of Hope-Lennar Foundation Cancer Center Irvine, California, United States
  • Usc Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Medical Hematology & Oncology Los Angeles, California, United States
View all 54 locations
View Trial Details
Recruiting

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

NCT07008118

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +8 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Mayo Clinic-Florida Jacksonville, Florida, United States
View all 26 locations
View Trial Details
Recruiting

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

NCT05320198

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • City of Hope - Duarte Duarte, California, United States
  • City of Hope - Lennar Irvine, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 28 locations
View Trial Details

Related conditions